Gestational Diabetes Companies

Dexcom Announced the launch of the G6 CGM System for pregnant women in January 2024, offering continuous glucose monitoring with reduced sensor wear time compared to previous versions.

Abbott Laboratories Introduced the FreeStyle Libre 3 System in October 2023, featuring a smaller and more durable CGM sensor for enhanced patient comfort.

Roche Diabetes Care Partnered with Voluntis to develop a digital health platform for gestational diabetes management, combining educational resources, glucose tracking, and personalized recommendations.

Glooko  Launched the Glooko Pro for Healthcare Providers platform in May 2023, enabling remote monitoring and data analysis of CGM data for gestational diabetes patients.

Vivante Health Expanded their telemedicine services to include gestational diabetes management, providing remote consultations and personalized care plans for pregnant women.

List of Gestational Diabetes Key Companies in the Market

• Antares Pharma (US)


• INJEX Pharma AG (Germany)


• 3M (US)


• Eli Lilly (US)


• Biocon (US)


• Sunpharma (India)


• Sanofi (France)


• Novo Nordisk (Denmark)


• Abbott (US)


• AstraZeneca (UK)


• Novartis (Switzerland)


• Daiichi Sankyo (Japan)


• Boehringer Ingelheim (Germany)


• Merck & Co. (US)


• Pfizer (US)


• Akros Pharma (US)


• Amgen (US)


• Adocia (France)


• Peptron (South Korea)


• Takeda (Japan)